Aastrid International Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.00 M
as on 16-11-2024
- Company Age 21 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.50 Cr
as on 16-11-2024
- Satisfied Charges ₹ 13.03 Cr
as on 16-11-2024
- Revenue -15.92%
(FY 2023)
- Profit -17.37%
(FY 2023)
- Ebitda -65.34%
(FY 2023)
- Net Worth 15.47%
(FY 2023)
- Total Assets 1.61%
(FY 2023)
About Aastrid International
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹6.50 Cr. The company has closed loans amounting to ₹13.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anupama Jagtap and Ravindra Jagtap serve as directors at the Company.
- CIN/LLPIN
U52310MH2003PTC139687
- Company No.
139687
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aastrid International?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindra Jagtap  | Managing Director | 24-Mar-2003 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anupama Jagtap | Director | 24-Mar-2003 | Current |
Financial Performance of Aastrid International.
Aastrid International Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.92% decrease. The company also saw a substantial fall in profitability, with a 17.37% decrease in profit. The company's net worth Soared by an impressive increase of 15.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aastrid International?
In 2023, Aastrid International had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aastrid Life Sciences Private LimitedActive 14 years 10 monthsAnupama Jagtap and Ravindra Jagtap are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 15 Nov 2019 | ₹6.50 Cr | Open |
Others Creation Date: 27 Sep 2017 | ₹7.25 Cr | Satisfied |
The Saraswat Cooperative Bank Ltd Creation Date: 26 Dec 2009 | ₹9.50 M | Satisfied |
How Many Employees Work at Aastrid International?
Aastrid International has a workforce of 32 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aastrid International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aastrid International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
